Trends in nucleoside tracers for PET imaging of cell proliferation

Nuclear Medicine and Biology

Volumn 30, Issue 7, 2003, Pages 681-685

  Toyohara, Jun ^a,b   Fujibayashi, Yasuhisa ^b  

^a Nihon Medi Physics   (Japan)

^b UNIVERSITY OF FUKUI   (Japan)

Author keywords

Nucleoside; PET; Proliferation

Indexed keywords

2 THYMIDINE C 11; 3' DEOXY 3' FLUOROTHYMIDINE F 18; 5 BROMO 2' DEOXYURIDINE BR 76; 5 BROMO(2 FLUORO 2 BETA DEXTRO ARABINOFURANOSYL)URACIL BR 76; 5 IODO 2' DEOXYURIDINE I 124; 5 METHYL(2 FLUORO 2 BETA DEXTRO ARABINOFURANOSYL)URACIL C 11; 5 METHYL(2 FLUORO 2 BETA DEXTRO ARABINOFURANOSYL)URACIL F 18; ARABINOTHYMIDINE H 3; BETA AMINOISOBUTYRIC ACID C 11; BETA UREIDOISOBUTYRIC ACID C 11; BROMINE 76; CARBON DIOXIDE C 11; DIHYDROTHYMINE C 11; FLOXURIDINE F 18; FLUORODEOXYGLUCOSE F 18; IDOXURIDINE I 131; METHYL THYMIDINE C 11; METHYLTHYMIDINE H 3; NUCLEOSIDE; THYMINE C 11; TRACER; UNCLASSIFIED DRUG;

BINDING AFFINITY; CELL PROLIFERATION; DNA SYNTHESIS; DRUG ACTIVITY; DRUG BINDING; DRUG HALF LIFE; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; ISOTOPE LABELING; MEDICAL RESEARCH; NONHODGKIN LYMPHOMA; POSITRON EMISSION TOMOGRAPHY; RADIOACTIVITY; REVIEW; TUMOR CELL;

EID: 0141671765     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(03)00084-2     Document Type: Article

References (44)

1. 18F-5-fluorodeoxyuridine in animals. Eur J Nucl Med. 8:1983;258-261.
2. 18F]-FMAU). J Label Compd Radiopharm. 45:2002;583-590.
3. Arnér E.S.J., Erikkson S.N. Mammalian deoxyribonucleoside kinases. Pharmac Ther. 67:1995;155-186.
4. 14C]FMAU) in rat prostate tumor cells. Nucl Med Biol. 27:2000;361-368.
5. 124I]iododeoxyuridine. Cancer Res. 60:2000;624-635.
6. Brown N.S., Bicknell R. Thymidine phosphorylase, 2-deoxy-D-ribose and angiogenesis. Biochem J. 334:1998;1-8.
7. 18F]fluorothymidine-positron emission tomography for noninvasive assessment of proliferation in pulmonary nodules. Cancer Res. 62:2002;3331-3334.
8. 11C]thymidine. Proc Natl Acad Sci USA. 69:1972;988-992.
9. 11C]-FMAU) a potential nucleoside analog for in vivo study of cellular proliferation with PET . Nucl Med Biol. 22:1995;783-789.
10. 11C-FMAU) Initial clinical studies . J Nucl Med. 43:(suppl 5):2002;26.
11. 18F]FLT uptake after chemotherapy an experimental study . Eur J Nucl Med Mol Imaging. 29:2002;1462-1469.
12. Eidinoff M., Chenong L., Rich M. Incorporation of unnatural pyrimidine bases into deoxyribonucleic acid of mammalian cells. Science. 129:1959;1550-1551.
13. 76Br-BrdU in DNA of brain tumors after a PET study does not support its use as a proliferation marker. Nucl Med Biol. 28:2001;59-65.
14. Gunn R.N., Yap J.T., Wells P., Osman S., Price P., Jones T., Cunningham V.J. A general method to correct PET data for tissue metabolites using a dual-scan approach. J Nucl Med. 41:2000;706-711.
15. 2 during PET. J Nucl Med. 41:2000;605-611.
16. Hengstschläger M., Knöfler M., Müllner E.W., Ogris E., Wintersberger, Wawra E. Different regulation of thymidine kinase during the cell cycle of normal versus DNA tumor virus-transformed cells. J Biol Chem. 269:1994;13836-13842.
17. Hengstschläger M., Pusch O., Hengstschläger-Ottnad E., Ambros P.F., Bernaschek G., Wawra E. Loss of the p16/MTS1 tumor suppressor gene causes E2F-mediated deregulation of essential enzymes of the DNA precursor metabolism. DNA Cell Biol. 15:1996;41-51.
18. Hengstschläger M., Hengstschläger-Ottnad E., Pusch O., Wawra E. The role of p16 in the E2F-dependent thymidine kinase regulation. Oncogene. 12:1996;1635-1643.
19. Howard A., Pelc S.R. Synthesis of deoxyribonucleic acid in normal and irradiated cells and its relation to chromosome breakage. Heredity. 6:(Suppl 1):1983;261-273.
20. 18F-5-fluorouridine in rats. Eur J Nucl Med. 9:1984;185-189.
21. 3H-deoxythymidine in tumor-bearing rats and mice. Eur J Nucl Med. 10:1985;39-44.
22. Johansson N.G., Eriksson S. Structure-activity relation ships for phosphorylation of nucleoside analogs to monophosphates by nucleoside kinases. Acta Biochemica Polonica. 43:1996;143-160.
23. Krueger R.C., Gitlin D., Commerford S.L., Stein J., Hughes W. Iododeoxyuridine as a tracer of DNA metabolism in vivo. Fed Proc. 19:1960;307.
24. 76Br]bromofluorodeoxyuridine and its validation with regard to uptake, DNA incorporation, and excretion modulation in rats. J Nucl Med. 41:2000;1746-1752.
25. Martiat P., Ferrant A., Labar D., Cogneau M., Bol A., Michel C., Michaux J.L., Sokal G. In vivo measurement of carbon-11 thymidine uptake in non-Hodgkin's lymphoma using positron emission tomography. J Nucl Med. 29:1988;1633-1637.
26. Munch-Petersen B., Cloos L., Jensen H.K., Tyrsted G. Human thymidine kinase 1. Regulation in normal and malignant cells. Advan Enzyme Regul. 35:1995;69-89.
27. 131I-5-iodo-2-deoxyuridine by malignant tumours in man. Br J Cancer. 63:1991;134-135.
28. Prusoff W. Incorporation of iododeoxyuridine, an analog of thymidine, into mammalian deoxyribonucleic acid. Fed Proc. 18:1959;305.
29. Prusoff W., Jaffe J., Gunther H. Studies in the mouse of pharmacology of 5-iododeoxyuridine, an analogue of thymidine. Biochem Pharmacol. 3:1960;110-121.
30. Rahim S.G., Trivedi N., Bogunovic-Batchelor M.V., Hardy G.W., Mills G., Selway J.W., Snowden W., Littler E., Coe P.L., Basnak I., Whale R.F., Walker R.T. Synthesis and anti-herpes virus activity of 2′-deoxy-4′ -thiopyrimidine nucleosides. J Med Chem. 39:1996;789-795.
31. Rasey S., Grierson J.R., Wiens L.W., Kolb P.D., Schwartz J.L. Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells. J Nucl Med. 43:2002;1210-1217.
32. Saito Y., Rubenstein R., Price R.W., Fox J.J., Watanabe K.A. Diagnostic imaging of herpes simplex virus encephalitis using a radiolabeled antiviral drug autoradiographic assessment in an animal model . Ann Neurol. 15:1984;548-558.
33. Sherley J.L., Kelly T.J. Regulation of human thymidine kinase during the cell cycle. J Biol Chem. 263:1988;8350-8358.
34. Shields A.F., Lim K., Grierson J., Link J., Krohn K.A. Utilization of labeled thymidine in DNA synthesis studies for PET . J Nucl Med. 31:1990;337-342.
35. Shields A.F., Mankoff D., Graham M.M., Zheng M., Kozawa S.M., Link J.M., Krohn K.A. Analysis of 2-carbon-11-thymidine blood metabolites in PET imaging. J Nucl Med. 37:1996;290-296.
36. Shields A.F., Grierson J.R., Dohmen B.M., Machulla H.J., Stayanoff J.C., Lawhorn-Crews J.M., Obradovich J.E., Muzik O., Mangner T.J. Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. Nat Med. 4:1998;1334-1336.
37. 18F-FMAU and PET. J Nucl Med. 43:(suppl 5):2002;26.
38. 11C labeled thymidine for tumor visualization using positron emission tomography . Int J Appl Radiat Isot. 35:1984;705-708.
39. 3H]arabinothymidine, and cell-analysis in 22 asynchronously growing tumor cell lines . Nucl Med Biol. 29:2002;281-287.
40. 125I-iodo-4′ -thio-2′-deoxyuridine as a potential iodinated proliferation marker. J Nucl Med. 43:2002;1218-1226.
41. Tjuvajev J.G., Macapinlac H.A., Daghighian F., Scott A.M., Ginos J.Z., Finn R.D., Kothari P., Desai R., Zhang J., Beattie B., et al. Imaging of brain tumor proliferative activity with iodine-131-iododeoxyuridine. J Nucl Med. 35:1994;1407-1417.
42. 11C]thymidine for quantification of cellular proliferation with PET. Int J Rad Appl Instrum. 42:1991;103-104.
43. Watanabe K.A., Reichman U., Hirota K., Lopez C., Fox J.J. Nucleosides. 110. Synthesis and antiherpes virus activity of some 2′-fluoro-2′ -deoxyarabinofuranosylpyrimidine nucleosides. J Med Chem. 22:1979;21-24.
44. Xerons N. Deoxyribose control and synchronization of mitosis. Nature. 194:1962;682-683.